Clinical Trial Update: Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating apixaban for prophylaxis to prevent left ventricular thrombus following anterior myocardial infarction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Thrombus
• Myocardial Infarction

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: National Institute of Cardiovascular Diseases, Pakistan | Conditions: Acute Myocardial Infarction of Anterior Wall, Left Ventricular Thrombus | Phase 3 | Status: RECRUITING